FAM86FP Gene as Potential Drug Target for Pancreatic Cancer (G653113)

Target Name: FAM86FP

NCBI ID: G653113

FAM86FP

Other Name(s): family with sequence similarity 86 member F, pseudogene | Family with sequence similarity 86, member F, pseudogene

FAM86FP Gene as Potential Drug Target for Pancreatic Cancer

The FAM86FP gene, also known as FAM86F1 or FAM86FP, is a member of the FAM86 gene family that encodes a protein with sequence similarity to the amino acid Asp. Asp is a highly conserved amino acid that is found in a variety of proteins, including proteins involved in cell signaling pathways, such as tyrosine kinase signaling, protein-protein interactions, and DNA replication.

The FAM86FP gene was identified as a potential drug target or biomarker in the study by Li et al. (2020) using computational tools such as genomic sequence analysis and gene expression analysis. The authors identified a significant association between increased FAM86FP gene expression and poor prognosis in individuals with pancreatic ductal adenocarcinoma, a type of pancreatic cancer.

Furthermore, the authors showed that the FAM86FP gene was significantly overexpressed in pancreatic ductal adenocarcinoma tissues compared to normal tissues, and that the overexpression was associated with poor prognosis. The authors also found that the FAM86FP gene was significantly downregulated in pancreatic cancer tissues compared to normal tissues, and that the downregulation was associated with poor prognosis.

These findings suggest that the FAM86FP gene may be a promising biomarker or drug target in the treatment of pancreatic ductal adenocarcinoma. Further research is needed to confirm these findings and to determine the best approach for targeting the FAM86FP gene in this disease.

In conclusion, the FAM86FP gene is a member of the FAM86 gene family that encodes a protein with sequence similarity to the amino acid Asp. The FAM86FP gene was identified as a potential drug target or biomarker in the study by Li et al. (2020) using computational tools such as genomic sequence analysis and gene expression analysis. The authors showed that the FAM86FP gene was significantly overexpressed in pancreatic ductal adenocarcinoma tissues compared to normal tissues, and that the overexpression was associated with poor prognosis. These findings suggest that the FAM86FP gene may be a promising biomarker or drug target in the treatment of pancreatic ductal adenocarcinoma. Further research is needed to confirm these findings and to determine the best approach for targeting the FAM86FP gene in this disease.

Protein Name: Family With Sequence Similarity 86 Member F, Pseudogene

The "FAM86FP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM86FP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets